Atai stock forecast.

NL0015000DX5. ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Berlin, Germany. Show more. The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors. 7 Stocks That AI Predicts Will Soar in 2024 InvestorPlace. Artificial intelligence (AI) has become an invaluable ...Weather forecasts are essential tools for planning our daily activities, especially when it comes to the next 10 days. Understanding a weather 10 day forecast can help us make informed decisions about outdoor events, travel plans, or even w...Track ATAI Life Sciences N.V. (ATAI) Stock Price, Quote, latest community messages, chart, news and other stock related information.43.55. -2.16%. 5.29M. Find the latest ATAI Life Sciences BV (ATAI) stock forecast, 12-month price target, predictions and analyst recommendations.Web

Dec 1, 2023 · View atai Life Sciences NV ATAI investment & stock information. Get the latest atai Life Sciences NV ATAI detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Nov 18, 2022 · (See ATAI stock forecast on TipRanks) SomaLogic . The next Wood pick we’ll look at is a protein biomarker discovery and clinical diagnostics company. SomaLogic operates in what is known as the ... NEW YORK and BERLIN, Sept. 14, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in the 2023 Cantor Fitzgerald Global Healthcare Conference. September 14, 2023. Press Release.

November 30, 2023. EPS forecast (this quarter) -$1.25. Annual revenue (last year) $244.7M. Annual profit (last year) -$358.7M. Net profit margin. Shares of the Peter Thiel -backed psychedelic start-up Atai Life Sciences jumped Friday on their first day of trading on Wall Street. The newly listed Nasdaq stock opened up 40% before pulling ...Dec 1, 2023 · Detailed statistics for Atai Life Sciences N.V. (ATAI) stock, including valuation metrics, financial numbers, share information and more. ... Analyst Forecast. The ... 1.100 USD 7 Days Forecast Get It Now! 1-Year Forecast * 0.000001 USD Historical index on US Stock Market : C "Should I invest in ATAI Life Sciences N.V. stock?" "Should I …Web

Atai Life Sciences (ATAI) Stock Forecast & Price Target $1.10 +0.01 (+0.92%) (As of 11/24/2023 ET) Compare Today's Range $1.08 $1.12 50-Day Range $1.06 $1.52 52 …Web

Find the latest Samsara Inc. (IOT) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid Term ...

Atai Life Sciences N.V. (ATAI.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Atai Life Sciences N.V. | Nasdaq: ...SOFI - SoFi Technologies Inc Stock quote - CNNMoney.comExela Technologies Inc () Stock Market info Recommendations: Buy or sell Exela Technologies stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Exela Technologies share forecasts, stock quote and buy / sell signals below.According to present data Exela Technologies's XELA shares and potentially its …According to the issued ratings of 1 analysts in the last year, the consensus rating for Arcadia Biosciences stock is Buy based on the current 1 buy rating for RKDA. The average twelve-month price prediction for Arcadia Biosciences is $15.00 with a high price target of $20.00 and a low price target of $10.00. Learn more on RKDA's analyst …Find the latest Navitas Semiconductor Corporation (NVTS) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short ...

You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.The average Bit Digital stock price prediction forecasts a potential upside of 55.04% from the current BTBT share price of $2.58. What is BTBT's forecast return on equity (ROE) for 2023-2024? (NASDAQ: BTBT) forecast ROE is N/A, which is considered weak.Even in a speculative industry, I believe the stock is undervalued by these few facts alone. ATAI holds: 450M cash and cash equivalents; 20% equity stake in CMPS (750M mktcp - 150M worth at current prices); and ATAI has a vast ip pipeline that includes 9 lead compounds. Curious as to the community’s thoughts here!Atai tumbled 32% to $6.82 per share, extending Tuesday’s slide into a second day. The stock is down about 55% from its June initial public offering price of $15. “It is imperative for me to be ...15. 6. 2021. ... Since Atai Life Sciences is only going public, we don't have any forecast for the stock. Also, being a clinical-stage company, we don't have ...Dividend History. Dividend Yield Chart. Learn more about Atai Life Sciences's (ATAI) dividend history, ex-dividend date, and yield. Zacks.com Our Research, Your Success.

Nov 29, 2023 · Atai Life Sciences Stock Price, News & Analysis (NASDAQ:ATAI) $1.10 +0.01 (+0.92%) (As of 11/24/2023 ET) Compare Today's Range $1.08 $1.12 50-Day Range $1.06 $1.52 52-Week Range $1.05 $3.65 Volume 272,978 shs Average Volume 997,775 shs Market Capitalization $182.61 million P/E Ratio N/A Dividend Yield N/A Price Target $12.80

According to 6 analyst offering 12-month price targets in the last 3 months, ATAI Life Sciences has an average price target of $15.33 with a high of $23.00 and a low of $9.00. Below is a summary ...ATA Inc-China Net Income Forecast for 2023 - 2025 - 2030. In the last year, ATA Inc-China has seen a decline in its Net Income, from $-169.84M to $-167.81M – a 1.20% decrease. In the next year, analysts predict that Net Income will reach $-169.84M – an increase of 1.21%. For the next nine years, the forecast is for Net Income to grow by 0.80%.Complete ATAI Life Sciences N.V. stock information by Barron's. View real-time ATAI stock price and news, along with industry-best analysis.The average Compass stock price prediction forecasts a potential upside of 35.39% from the current COMP share price of $2.43. What is COMP's forecast return on equity ...On July 10, 2023, the stock experienced a significant increase, driven by positive forecasts and a strong consensus among investment analysts. According to data from CNN Money, the 12-month price forecasts for ATAI stock have a median target of 11.00, with a high estimate of 21.00 and a low estimate of 6.00.NeuBase Therapeutics' stock was trading at $3.8040 on January 1st, 2023. Since then, NBSE stock has decreased by 82.2% and is now trading at $0.6758. View the best growth stocks for 2023 here. Are investors shorting NeuBase Therapeutics? NeuBase Therapeutics saw a decrease in short interest in the month of October.As of the end of March 2023, the ETF’s portfolio worth fell to $7.4 billion, as Cathie Wood started to sell stocks last year. According to a Bloomberg report, because of selling stocks at a loss ...The total addressable market for AI is massive; by 2030, it's expected to be worth nearly $2 trillion, according to Statista. That's a massive pie, and multiple companies will be vying for these ...

ATAI Stock 12 Months Forecast. $14.00. (960.61% Upside) Based on 4 Wall Street analysts offering 12 month price targets for ATAI Life Sciences in the last 3 months. The average price target is $14.00 with a high forecast of $20.00 and a low forecast of $11.00. The average price target represents a 960.61% change from the last price of $1.32.

Find the latest Navitas Semiconductor Corporation (NVTS) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short ...

Find the latest Jet.AI Inc. (JTAI) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid Term ...RPHM. Reneo Pharmaceuticals Inc. 6.04. +0.10. +1.68%. Get ATAI Life Sciences NV (ATAI:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.Find real-time SMCI - Super Micro Computer Inc stock quotes, company profile, news and forecasts from CNN Business.Part of ATAI stock’s negative performance can be attributed to some poor clinical trial results. The company began the year by announcing disappointing news regarding a Phase 2 trial for PCN-101 ...Find latest ATAI Life Sciences N.V. (ATAI) stock discussions and message board on Twitter, StocksTwits, Reddit, SeekingAlpha and other social media. Stock Screener App. Free - Install. Dark EN. Sign in. ... Discussions Forecast. ATAI Life Sciences N.V. (ATAI) Stock Discussion & Message BoardWhat is the current Price Target and Forecast for atai Life Sciences (ATAI) atai Life Sciences (ATAI) (Delayed Data from NSDQ) $1.12 USD +0.08 (7.69%) Updated …WebThis was the ETF and Ark Invest’s first purchase of ATAI stock since March 14. From March 14 to July 5, ATAI stock declined by 27%. After the recent purchases, ARKG now owns a total of 1.82 ...The ATAI Life Sciences N.V. stock forecast is 6.0790759618269 USD for 2024 November 11, Monday; and 24.831 USD for 2028 November 11, Saturday with technical analysis. ATAI Life Sciences N.V. (ATAI) stock price prediction is 6.0790759618269 USD.-15.00(-0.11%) Russell 2000 1,807.50 +11.96(+0.67%) Crude Oil 75.54 -1.56(-2.02%) Gold 2,003.00 +10.20(+0.51%) Atai Life Sciences N.V. (ATAI) NasdaqGM - NasdaqGM Real Time Price. Currency in...ATAI Life Sciences NV (ATAI) stock is trading at $2.17 as of 1:48 PM on Monday, Jul 17, a gain of $0.15, or 7.55% from the previous closing price of $2.02. The stock has traded between $2.00 and $2.20 so far …Atai Life Sciences ( ATAI 2.80%), a small-cap drugmaker developing psychedelic-based treatments for drug dependency and mental health disorders, posted strong gains during the first four days of ...

CYBN Stock 12 Months Forecast. $5.50. (1067.48% Upside) Based on 4 Wall Street analysts offering 12 month price targets for Cybin in the last 3 months. The average price target is $5.50 with a high forecast of $10.00 and a low forecast of $3.00. The average price target represents a 1067.48% change from the last price of $0.47.Atai Life Sciences. One of Atai Life Sciences' early investors was venture capitalist Peter Thiel. The company went public in June 2021 at $15 and is currently trading at $3.78 with a market cap ...Atai Life Sciences N.V. Market Cap: 184.27M, Enterprise value: 101.26M, P/E: -1.93, PEG ratio: -0.17, EPS: -0.42, Revenue: 334K, EBITDA: -129.47M, ...Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $214.15M. -60.0%. Market Cap / Employee. The market cap of a ...Instagram:https://instagram. first national realty partners minimum investmentfisker stocks5 dollar stockspy cost ATAI Stock 12 Months Forecast. $14.00. (960.61% Upside) Based on 4 Wall Street analysts offering 12 month price targets for ATAI Life Sciences in the last 3 months. The average price target is $14.00 with a high forecast of $20.00 and a low forecast of $11.00. The average price target represents a 960.61% change from the last price of $1.32. how much is 1943 penny worthfinancial advising software The average Bit Digital stock price prediction forecasts a potential upside of 55.04% from the current BTBT share price of $2.58. What is BTBT's forecast return on equity (ROE) for 2023-2024? (NASDAQ: BTBT) forecast ROE is N/A, which is considered weak.ATAI Life Sciences N.V., a clinical-stage biopharmaceutical company, engages in acquiring, incubating, and developing various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. Its principal clinical programs include RL-007, a pro-cognitive neuromodulator for cognitive impairment associated with ... nasdaq kfrc Neogenomics Inc. () Stock Market info Recommendations: Buy or sell Neogenomics stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Neogenomics share forecasts, stock quote and buy / sell signals below.According to present data Neogenomics's NEO shares and potentially its market environment have …ATAI Life Sciences N.V. (ATAI) stock price prediction is 6.0790759618269 USD. The ATAI Life Sciences N.V. stock forecast is 6.0790759618269 USD for 2024 November 11, Monday; and 24.831 USD for 2028 November 11, Saturday with technical analysis.